Auravax Therapeutics, Inc.

Houston, TX Auravax

UEI
PAN3ZK2YLAL2
CAGE
969E2
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
807 Wendel St, Houston, TX 77009, USA
Website
auravax.com
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Auravax Therapeutics, Inc.'s latest federal award, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
The overall objective of this contract is to assess the ability of auravax therapeutics? (auravax) novel mucosal… Contract · 75A50124C00054 Office of the Assistant Secretary for Preparedness and Response $749,999

Quick answers

What is Auravax Therapeutics, Inc.'s UEI?

Auravax Therapeutics, Inc.'s Unique Entity ID (UEI) in SAM.gov is PAN3ZK2YLAL2.

What is Auravax Therapeutics, Inc.'s CAGE code?

Auravax Therapeutics, Inc.'s CAGE code is 969E2.

What is Auravax Therapeutics, Inc.'s primary NAICS code?

Auravax Therapeutics, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Where is Auravax Therapeutics, Inc. located?

Auravax Therapeutics, Inc.'s physical address in SAM.gov is 807 Wendel St, Houston, TX 77009, USA.

Is Auravax Therapeutics, Inc. registered in SAM.gov?

Yes. Auravax Therapeutics, Inc.'s SAM.gov registration is active through January 21, 2027.

What is Auravax Therapeutics, Inc.'s most recent federal award?

Auravax Therapeutics, Inc.'s most recent federal contract award is The overall objective of this contract is to assess the ability of auravax therapeutics? (auravax) novel mucosal… (75A50124C00054), from Office of the Assistant Secretary for Preparedness and Response, on September 23, 2024.

On GovTribe

See Auravax Therapeutics, Inc.'s full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login